215 related articles for article (PubMed ID: 33584198)
1. Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments.
Satta V; Alonso C; Díez P; Martín-Suárez S; Rubio M; Encinas JM; Fernández-Ruiz J; Sagredo O
Front Mol Neurosci; 2020; 13():602801. PubMed ID: 33584198
[TBL] [Abstract][Full Text] [Related]
2. Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome.
Alonso C; Satta V; Díez-Gutiérrez P; Fernández-Ruiz J; Sagredo O
Neuropharmacology; 2022 Mar; 205():108914. PubMed ID: 34875285
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1a
Alonso C; Satta V; Hernández-Fisac I; Fernández-Ruiz J; Sagredo O
Neuropharmacology; 2023 Oct; 237():109602. PubMed ID: 37290534
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA
Nakakubo S; Hiramatsu Y; Goto T; Kimura S; Narugami M; Nakajima M; Ueda Y; Shiraishi H; Manabe A; Sharmin D; Cook JM; Egawa K
Front Pharmacol; 2023; 14():1273633. PubMed ID: 37849734
[No Abstract] [Full Text] [Related]
5. Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model.
Salazar JJ; Satriano A; Matamoros JA; Fernández-Albarral JA; Salobrar-García E; López-Cuenca I; de Hoz R; Sánchez-Puebla L; Ramírez JM; Alonso C; Satta V; Hernández-Fisac I; Sagredo O; Ramírez AI
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769051
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.
Ricobaraza A; Mora-Jimenez L; Puerta E; Sanchez-Carpintero R; Mingorance A; Artieda J; Nicolas MJ; Besne G; Bunuales M; Gonzalez-Aparicio M; Sola-Sevilla N; Valencia M; Hernandez-Alcoceba R
Sci Rep; 2019 Oct; 9(1):14172. PubMed ID: 31578435
[TBL] [Abstract][Full Text] [Related]
7. Behavioral phenotyping of young Scn1a haploinsufficient mice.
Reiber M; Miljanovic N; Schönhoff K; Palme R; Potschka H
Epilepsy Behav; 2022 Nov; 136():108903. PubMed ID: 36240579
[TBL] [Abstract][Full Text] [Related]
8. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome.
Martín-Suárez S; Abiega O; Ricobaraza A; Hernandez-Alcoceba R; Encinas JM
Front Cell Dev Biol; 2020; 8():654. PubMed ID: 32793597
[TBL] [Abstract][Full Text] [Related]
10. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
[TBL] [Abstract][Full Text] [Related]
11. Impairments in social novelty recognition and spatial memory in mice with conditional deletion of Scn1a in parvalbumin-expressing cells.
Tatsukawa T; Ogiwara I; Mazaki E; Shimohata A; Yamakawa K
Neurobiol Dis; 2018 Apr; 112():24-34. PubMed ID: 29337050
[TBL] [Abstract][Full Text] [Related]
12. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
[TBL] [Abstract][Full Text] [Related]
13. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
14. Dravet Variant
Layer N; Sonnenberg L; Pardo González E; Benda J; Hedrich UBS; Lerche H; Koch H; Wuttke TV
Front Cell Neurosci; 2021; 15():754530. PubMed ID: 34776868
[TBL] [Abstract][Full Text] [Related]
15. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
16. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
Lopez-Santiago L; Isom LL
Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
[TBL] [Abstract][Full Text] [Related]
17. Transfer of
Mora-Jimenez L; Valencia M; Sanchez-Carpintero R; Tønnesen J; Fadila S; Rubinstein M; Gonzalez-Aparicio M; Bunuales M; Fernandez-Pierola E; Nicolas MJ; Puerta E; Miguelez C; Minguez PG; Lumbreras S; Gonzalez-Aseguinolaza G; Ricobaraza A; Hernandez-Alcoceba R
Mol Ther Nucleic Acids; 2021 Sep; 25():585-602. PubMed ID: 34589280
[TBL] [Abstract][Full Text] [Related]
18. A more efficient conditional mouse model of Dravet syndrome: Implications for epigenetic selection and sex-dependent behaviors.
Williams AD; Kalume F; Westenbroek RE; Catterall WA
J Neurosci Methods; 2019 Sep; 325():108315. PubMed ID: 31265868
[TBL] [Abstract][Full Text] [Related]
19. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
[TBL] [Abstract][Full Text] [Related]
20. Heat-induced seizures, premature mortality, and hyperactivity in a novel
Mavashov A; Brusel M; Liu J; Woytowicz V; Bae H; Chen YH; Dani VS; Cardenal-Muñoz E; Spinosa V; Aibar JÁ; Rubinstein M
Front Cell Neurosci; 2023; 17():1149391. PubMed ID: 37206664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
